tiprankstipranks
Trending News
More News >
Positive Buy Rating for EyePoint Pharmaceuticals Driven by Clinical Progress and Strong Financial Position
PremiumRatingsPositive Buy Rating for EyePoint Pharmaceuticals Driven by Clinical Progress and Strong Financial Position
25d ago
EyePoint Pharma’s Promising Q1 2025 Financial Results
Premium
Company Announcements
EyePoint Pharma’s Promising Q1 2025 Financial Results
1M ago
EyePoint Pharma’s Earnings Call Highlights Positive Momentum
Premium
Company Announcements
EyePoint Pharma’s Earnings Call Highlights Positive Momentum
1M ago
Is EYPT a Buy, Before Earnings?
PremiumPre-EarningsIs EYPT a Buy, Before Earnings?
1M ago
EyePoint reports inducement grants under NASDAQ listing rule
Premium
The Fly
EyePoint reports inducement grants under NASDAQ listing rule
2M ago
EyePoint reports inducement grants under NASDAQ listing rule
Premium
The Fly
EyePoint reports inducement grants under NASDAQ listing rule
3M ago
EyePoint expects cash to fund operations into 2027
PremiumThe FlyEyePoint expects cash to fund operations into 2027
3M ago
Eyepoint Pharma (EYPT) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Eyepoint Pharma (EYPT) Q4 Earnings Cheat Sheet
3M ago
EyePoint Pharmaceuticals: Buy Rating Backed by Promising Duravyu Phase 2 Results and Growth Potential in Undervalued Market
Premium
Ratings
EyePoint Pharmaceuticals: Buy Rating Backed by Promising Duravyu Phase 2 Results and Growth Potential in Undervalued Market
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100